Cathie Wood Loads Up $23M In Gene-Editing Company’s Shares As They Slump 10% In A Month
Cathie Wood-led Ark Investment Management on Friday raised its stake in clinical stage genetics medicine company Verve Therapeutics Inc (NASDAQ: VERV) via two of its exchange-traded funds.
Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday
Gainers
Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.
Why NCR Is Trading Lower By Around 23%, Here Are 42 Stocks Moving In Friday’s Mid-Day Session
Gainers
Kensington Capital Acquisition Corp. IV (NYSE: AMPX) jumped 35.4% to $13.54 after gaining 11% on Thursday.
Stifel Upgrades Verve Therapeutics to Buy, Raises Price Target to $56
Stifel analyst Dae Gon Ha upgrades Verve Therapeutics (NASDAQ:VERV) from Hold to Buy and raises the price target from $32 to $56.
Turquoise Hill Resources, Intuit And Some Other Big Stocks Moving Higher On Wednesday
Turquoise Hill Resources Ltd. (NYSE: TRQ) climbed 25% to $29.14 after Rio Tinto Group raised its offer to buy out Turquoise Hill Resources.
Macy’s, Palo Alto Networks And Other Big Gainers From Tuesday
U.S. stocks closed mostly lower with the Dow Jones dropping more than 150 points on Tuesday. Here is the list of some big stocks moving higher in the previous session.